Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan's EPS Manager Takehiro Minami On What It Takes To Go Global: An Interview with PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Established in 1991 as a data management company, EPS has become one of the two top-tier contract research organizations in Japan. In part one of this interview, EPS Manager, Office of the President, Takehiro Minami, spoke with PharmAsia News about the company's beginnings and how it has expanded its business in Japan. In this second segment, he discusses the company's business development strategy for emerging markets, as well as in Japan.

You may also be interested in...



Japanese Regulators, With Drug Makers Support, Moves Toward East Asian Clinical Data Sharing And Acceptance

Japan is determined to further an initiative in promoting multi-regional clinical study data acceptance among East Asian countries, and the proposal has gained critical support from the nation's drug making industry

Japanese Regulators, With Drug Makers Support, Moves Toward East Asian Clinical Data Sharing And Acceptance

Japan is determined to further an initiative in promoting multi-regional clinical study data acceptance among East Asian countries, and the proposal has gained critical support from the nation's drug making industry

EPS Manager Takehiro Minami On Growing A Japanese CRO Into A Global Provider: An Interview with PharmAsia News (Part 1 of 2)

Established in 1991 as a data management company, EPS has become one of the two top-tier contract research organizations in Japan. Founded by Dr. Hao Yan, EPS is now a First Section-listed company on the Tokyo Stock Exchange, and one of only two foreign-established First Section-listed companies in 60 years of TSE history. When the company was founded, Yan was a Chinese graduate student majoring in medical statistics at the University of Tokyo. With more than 2,000 employees, EPS offers major clinical trial services together with software and systems development, and operates in Singapore, Taiwan, South Korea, the Philippines and mainland China.

Related Content

UsernamePublicRestriction

Register

SC073166

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel